No-charge* IRD genetic testing program

Invitae is offering a genetic testing program sponsored by Spark® Therapeutics at no charge for individuals suspected of having an IRD. This program provides access to a broad inherited retinal disease genetic panel that tests approximately 300 genes for variants that are associated with IRDs.
*Subject to terms and conditions of program. The patient is responsible for any other costs that may be incurred as a result of participating in the program. Including, but not limited to, the costs of visits or consultations with their healthcare professional in connection with the genetic test or the testing results.

Program eligibility

This gene testing initiative is appropriate for patients suspected of having an IRD (e.g., retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease, etc.) and who have experienced one or more of the following:

  • Peripheral field loss
  • Nyctalopia
  • Deterioration in color vision
  • Central vision loss
  • Photophobia 
  • Any of the above with syndromic findings

Note: This program does not test for genes associated with age-related macular degeneration.

Benefits of testing

The benefits of genetic testing include the ability to:

  • Identify risk of disease for patients and their family members
  • Shorten the time to diagnosis and help prevent misdiagnosis
  • Help patients focus their search for clinical trials
  • Connect you to support services such as patient advocacy organizations
Learn more about IRD diagnosis and care

Invitae Inherited Retinal Disorders Panel

The Invitae Inherited Retinal Disorders Panel tests approximately 300 genes for variants that are associated with IRDs. Once Invitae receives the sample, you will receive results within 10 to 21 calendar days, on average. 


How to order

1. Submit an order

To place your online order, click here and follow the on-screen prompts.

To place a paper-based order, download the paper order form and the patient authorization form. Please include both forms in the specimen box when returning the sample. 

2. Collect a specimen

If a specimen collection kit was not ordered during the online ordering workflow, order a blood, buccal, or saliva collection kit here
Please view specimen and shipping requirements for important information, and be sure to include the completed requisition form in the kit with the specimen. 

3. Receive results

On average, results are available 10-21 days after Invitae receives the specimen. You will receive a notification email once the test results are ready.
Log in to view the status of your online order. 

Support every step of the way

Client services

Available to answer your questions or help you through the testing process.

  • Monday-Friday 5:00 am to 5:00 pm Pacific

  • Phone: 800-436-3037

Genetic counseling

Individuals tested through the Spark ID YOUR IRD® program will be eligible for no-charge, post-test genetic counseling to help them understand their test results. Invitae's genetic counseling services include:

  • Review of the patient's medical history and family history
  • Review of the patient’s genetic test results and the implications of those results for the patient and their family
  • A detailed consult note and pedigree made available to the patient and clinician after the genetic counseling session is complete

Confidence begins with quality

  • Commitment to quality: Invitae’s >1000 patient peer-reviewed study, published in the Journal Molecular Diagnostics, the official journal of the Association for Molecular Pathology, shows equivalence to established standards.
  • Sample options: blood and saliva kits provided free of charge.
  • Strong team: Invitae has more than 300 experts in genetics, bioinformatics, engineering, technology, and commercial development.

About Invitae

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit

About Spark Therapeutics

Spark Therapeutics — a fully integrated, commercial company committed to discovering, developing and delivering gene therapies — challenges the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases. We see the path to a world where no life is limited by genetic disease. For more information, visit, and follow us on Twitter and LinkedIn.

While Spark provides financial support for this program, tests and services are performed by independent third parties. Healthcare professionals must confirm that patients meet certain criteria to use the program. In accordance with the terms and conditions of the program, patients must consent to disclose personally identifying information and genetic test results to Spark. Spark also receives contact information for healthcare professionals who consent and use this program. Genetic testing and counseling are available in the US only. Healthcare professionals who use this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any Spark product. Please review all terms and conditions of the program before submitting test samples.

Spark and ID YOUR IRD and its design are trademarks or registered trademarks of Spark Therapeutics, Inc. in the United States and other countries.